# Investigation of Eluxadoline for Diabetic Diarrhea

> **NCT04313088** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Temple University**

## Conditions studied

- Diabetic Diarrhea
- Diabetes
- Diarrhea

## Interventions

- **DRUG:** Eluxadoline 100 mg

## Key facts

- **NCT ID:** NCT04313088
- **Lead sponsor:** Temple University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-07-01
- **Primary completion:** 2023-12
- **Final completion:** 2024-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This study did not enroll any subjects
- **Last updated:** 2023-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04313088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04313088, "Investigation of Eluxadoline for Diabetic Diarrhea". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT04313088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*